STATE OF WISCONSIN INVESTMENT BOARD - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$885,415
+57.5%
15,250
+46.0%
0.00%
+50.0%
Q2 2023$562,093
+29.6%
10,442
-4.4%
0.00%
+100.0%
Q1 2023$433,782
-11.1%
10,921
-10.0%
0.00%
-50.0%
Q4 2022$487,990
+17.6%
12,130
-6.0%
0.00%
+100.0%
Q3 2022$415,000
+0.5%
12,909
-12.2%
0.00%0.0%
Q1 2022$413,000
-8.6%
14,700
+17.6%
0.00%0.0%
Q1 2021$452,000
+24.5%
12,5000.0%0.00%0.0%
Q4 2020$363,000
-8.8%
12,500
-11.3%
0.00%0.0%
Q3 2020$398,000
-16.2%
14,100
-4.1%
0.00%0.0%
Q2 2020$475,000
-17.2%
14,700
+4.3%
0.00%
-50.0%
Q1 2020$574,000
-32.1%
14,100
+2.9%
0.00%0.0%
Q4 2019$845,000
-15.3%
13,7000.0%0.00%
-33.3%
Q3 2019$998,000
+4.6%
13,700
+18.1%
0.00%0.0%
Q2 2019$954,000
+26.4%
11,600
+8.4%
0.00%
+50.0%
Q1 2019$755,000
+101.9%
10,700
+28.9%
0.00%
+100.0%
Q4 2018$374,000
+10.3%
8,300
+38.3%
0.00%0.0%
Q3 2018$339,000
-15.5%
6,0000.0%0.00%0.0%
Q2 2018$401,000
+14.9%
6,0000.0%0.00%0.0%
Q1 2018$349,000
-9.8%
6,0000.0%0.00%0.0%
Q4 2017$387,000
+22.9%
6,0000.0%0.00%0.0%
Q3 2017$315,000
+12.1%
6,0000.0%0.00%0.0%
Q2 2017$281,0006,0000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders